{"id":33445,"date":"2010-06-15T11:43:36","date_gmt":"2010-06-15T10:43:36","guid":{"rendered":"http:\/\/www.corporate-eye.com\/blog\/?p=33445"},"modified":"2021-01-07T17:50:23","modified_gmt":"2021-01-07T16:50:23","slug":"effective-investor-relations-sites-pt-18","status":"publish","type":"post","link":"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/","title":{"rendered":"What Makes for Effective Investor Relations Sites?  Part 18: What\u2019s Your Strategy?"},"content":{"rendered":"<p>In terms of financial theory, investors buy stock in a company on the expectation that future cash flows from the company will be enough to repay the investment and pay a return over a foreseeable time horizon. In order to do this, investors must have some visibility into the potential for future profits. This is where the job of investor relations comes in. Clarifying how the company will meet challenges going forward to pay out returns to shareholders is a three-fold task:<\/p>\n<div class=\"pqRight\"><a href=\"https:\/\/www.corporate-eye.com\/main\/wp-content\/uploads\/2010\/06\/Shire-pharma-strategy.jpg\"><img decoding=\"async\" title=\"Shire Strategy\" alt=\"Shire Strategy\" data-src=\"https:\/\/www.corporate-eye.com\/main\/wp-content\/uploads\/2010\/06\/Shire-pharma-strategy-sm.jpg\" width=\"300\" height=\"256\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\" style=\"--smush-placeholder-width: 300px; --smush-placeholder-aspect-ratio: 300\/256;\" \/><\/a><\/div>\n<ul>\n<li>making sure people clearly understand the company, its products and markets<\/li>\n<li>laying down a vision for how the company\u2019s strategy will move the enterprise forward in the future<\/li>\n<li>and giving them a transparent view into how the company\u2019s profits were garnered in the past.<\/li>\n<\/ul>\n<div class=\"clearall\"><\/div>\n<p>One can argue on the relative importance of each of these messages. In fact, it\u2019s a bit like a three-legged stool in that each element is essential to the overall investment story. Without an understanding of how a firm will make its profits in the future an investor will not be likely to ante up his money. Similarly, if the organization, its products and markets are not understood, an investor will have little confidence in the enterprise. Finally, if an investor cannot look at past performance of the enterprise as a gauge to how they will perform in the future, conviction that management will deliver for the investor will be lacking.<\/p>\n<p>Today, however, I want to focus on the forward-looking piece of the story, as this is probably the area that we see the least in investor web sites. Most web sites are good at giving you information about past performance, particularly financial performance. Relatively fewer give you a glimpse into where they want the company to go.<\/p>\n<p>One company that does is <a href=\"http:\/\/www.shire.com\">Shire Pharmaceuticals<\/a>. While no single page description on the web can purport to give a full discussion of a company\u2019s strategy, Shire\u2019s page (see above), does give the reader some essential basics, such as their focus on specialty biopharmaceuticals and their use of strategic partnerships to develop most of the drugs in their pipeline.<\/p>\n<div class=\"pqRight\"><a href=\"https:\/\/www.corporate-eye.com\/main\/wp-content\/uploads\/2010\/06\/Compass-Strategy.jpg\"><img decoding=\"async\" class=\"alignnone size-full wp-image-33531 lazyload\" title=\"Compass Strategy\" alt=\"Compass Strategy\" data-src=\"https:\/\/www.corporate-eye.com\/main\/wp-content\/uploads\/2010\/06\/Compass-Strategy-sm.jpg\" width=\"300\" height=\"259\" data-srcset=\"https:\/\/www.corporate-eye.com\/main\/wp-content\/uploads\/2010\/06\/Compass-Strategy-sm.jpg 300w, https:\/\/www.corporate-eye.com\/main\/wp-content\/uploads\/2010\/06\/Compass-Strategy-sm-150x129.jpg 150w\" data-sizes=\"(max-width: 300px) 100vw, 300px\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" style=\"--smush-placeholder-width: 300px; --smush-placeholder-aspect-ratio: 300\/259;\" \/><\/a><\/div>\n<p>Another example is the Compass Group\u2019s Strategy page. Although there is a fair amount of corporate-speak jargon (Who doesn\u2019t want to deliver value to shareholders and customers; and what do they mean by \u201cleveraging the benefits of being a Group\u201d?), there are some useful pieces of information about what <a href=\"http:\/\/www.compass-group.co.uk\/\">Compass<\/a> wants to do and how they propose to do it once you get past the fuzzy language.<\/p>\n<div class=\"clearall\"><\/div>\n<p>To summarize, a company\u2019s message will be much more effective if they devote more space and effort on their web sites to telling investors where they want the company to go in the future and how they intend to get there.<\/p>\n<p>In this series:<br \/>\nPrevious post: <a href=\"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-17\/\">Making the individual shareholder feel welcome<\/a><br \/>\nNext post: <a href=\"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-19\/\">Help your most frequent visitors<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In terms of financial theory, investors buy stock in a company on the expectation that future cash flows from the company will be enough to repay the investment and pay a return over a foreseeable time horizon. In order to do this, investors must have some visibility into the potential for future profits. This is [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":33530,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[9,1145,3],"tags":[8244,75,267],"class_list":{"0":"post-33445","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-best-practices","8":"category-featured","9":"category-investor","10":"tag-investor","11":"tag-investor-relations","12":"tag-strategy","13":"entry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Investor Relations Sites - Strategy<\/title>\n<meta name=\"description\" content=\"Investors want to know the future direction of the company and how they intend to get there\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Investor Relations Sites - Strategy\" \/>\n<meta property=\"og:description\" content=\"Investors want to know the future direction of the company and how they intend to get there\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/\" \/>\n<meta property=\"og:site_name\" content=\"Corporate Eye\" \/>\n<meta property=\"article:published_time\" content=\"2010-06-15T10:43:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-01-07T16:50:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.corporate-eye.com\/main\/wp-content\/uploads\/2010\/06\/Shire-pharma-strategy.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"580\" \/>\n\t<meta property=\"og:image:height\" content=\"494\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lucy Nixon\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@lucynixon\" \/>\n<meta name=\"twitter:site\" content=\"@lucynixon\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lucy Nixon\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/\"},\"author\":{\"name\":\"Lucy Nixon\",\"@id\":\"https:\/\/www.corporate-eye.com\/main\/#\/schema\/person\/d273bf7421dc8f5fec96785876b760e2\"},\"headline\":\"What Makes for Effective Investor Relations Sites? Part 18: What\u2019s Your Strategy?\",\"datePublished\":\"2010-06-15T10:43:36+00:00\",\"dateModified\":\"2021-01-07T16:50:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/\"},\"wordCount\":499,\"commentCount\":1,\"publisher\":{\"@id\":\"https:\/\/www.corporate-eye.com\/main\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.corporate-eye.com\/main\/wp-content\/uploads\/2010\/06\/Shire-pharma-strategy.jpg\",\"keywords\":[\"Investor\",\"investor relations\",\"strategy\"],\"articleSection\":[\"Best Practices\",\"Featured\",\"Investor\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/\",\"url\":\"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/\",\"name\":\"Investor Relations Sites - Strategy\",\"isPartOf\":{\"@id\":\"https:\/\/www.corporate-eye.com\/main\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.corporate-eye.com\/main\/wp-content\/uploads\/2010\/06\/Shire-pharma-strategy.jpg\",\"datePublished\":\"2010-06-15T10:43:36+00:00\",\"dateModified\":\"2021-01-07T16:50:23+00:00\",\"description\":\"Investors want to know the future direction of the company and how they intend to get there\",\"breadcrumb\":{\"@id\":\"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/#primaryimage\",\"url\":\"https:\/\/www.corporate-eye.com\/main\/wp-content\/uploads\/2010\/06\/Shire-pharma-strategy.jpg\",\"contentUrl\":\"https:\/\/www.corporate-eye.com\/main\/wp-content\/uploads\/2010\/06\/Shire-pharma-strategy.jpg\",\"width\":580,\"height\":494,\"caption\":\"Shire Strategy\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.corporate-eye.com\/main\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"What Makes for Effective Investor Relations Sites? Part 18: What\u2019s Your Strategy?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.corporate-eye.com\/main\/#website\",\"url\":\"https:\/\/www.corporate-eye.com\/main\/\",\"name\":\"Corporate Eye\",\"description\":\"...compare, compete, excel\",\"publisher\":{\"@id\":\"https:\/\/www.corporate-eye.com\/main\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.corporate-eye.com\/main\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.corporate-eye.com\/main\/#organization\",\"name\":\"Corporate Eye\",\"url\":\"https:\/\/www.corporate-eye.com\/main\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.corporate-eye.com\/main\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.corporate-eye.com\/main\/wp-content\/uploads\/2019\/11\/corporate-eye-logo.png\",\"contentUrl\":\"https:\/\/www.corporate-eye.com\/main\/wp-content\/uploads\/2019\/11\/corporate-eye-logo.png\",\"width\":283,\"height\":42,\"caption\":\"Corporate Eye\"},\"image\":{\"@id\":\"https:\/\/www.corporate-eye.com\/main\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/lucynixon\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.corporate-eye.com\/main\/#\/schema\/person\/d273bf7421dc8f5fec96785876b760e2\",\"name\":\"Lucy Nixon\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.corporate-eye.com\/main\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/538dc739f95aa5a2fd75d054808b18b2afa37a9282a7a8f87001a77dc128d759?s=96&d=identicon&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/538dc739f95aa5a2fd75d054808b18b2afa37a9282a7a8f87001a77dc128d759?s=96&d=identicon&r=g\",\"caption\":\"Lucy Nixon\"},\"description\":\"Lucy is Editor at Corporate Eye\",\"sameAs\":[\"http:\/\/www.corporate-eye.com\",\"https:\/\/x.com\/lucynixon\"],\"url\":\"https:\/\/www.corporate-eye.com\/main\/author\/lucy\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Investor Relations Sites - Strategy","description":"Investors want to know the future direction of the company and how they intend to get there","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/","og_locale":"en_US","og_type":"article","og_title":"Investor Relations Sites - Strategy","og_description":"Investors want to know the future direction of the company and how they intend to get there","og_url":"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/","og_site_name":"Corporate Eye","article_published_time":"2010-06-15T10:43:36+00:00","article_modified_time":"2021-01-07T16:50:23+00:00","og_image":[{"width":580,"height":494,"url":"https:\/\/www.corporate-eye.com\/main\/wp-content\/uploads\/2010\/06\/Shire-pharma-strategy.jpg","type":"image\/jpeg"}],"author":"Lucy Nixon","twitter_card":"summary_large_image","twitter_creator":"@lucynixon","twitter_site":"@lucynixon","twitter_misc":{"Written by":"Lucy Nixon","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/#article","isPartOf":{"@id":"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/"},"author":{"name":"Lucy Nixon","@id":"https:\/\/www.corporate-eye.com\/main\/#\/schema\/person\/d273bf7421dc8f5fec96785876b760e2"},"headline":"What Makes for Effective Investor Relations Sites? Part 18: What\u2019s Your Strategy?","datePublished":"2010-06-15T10:43:36+00:00","dateModified":"2021-01-07T16:50:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/"},"wordCount":499,"commentCount":1,"publisher":{"@id":"https:\/\/www.corporate-eye.com\/main\/#organization"},"image":{"@id":"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/#primaryimage"},"thumbnailUrl":"https:\/\/www.corporate-eye.com\/main\/wp-content\/uploads\/2010\/06\/Shire-pharma-strategy.jpg","keywords":["Investor","investor relations","strategy"],"articleSection":["Best Practices","Featured","Investor"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/","url":"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/","name":"Investor Relations Sites - Strategy","isPartOf":{"@id":"https:\/\/www.corporate-eye.com\/main\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/#primaryimage"},"image":{"@id":"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/#primaryimage"},"thumbnailUrl":"https:\/\/www.corporate-eye.com\/main\/wp-content\/uploads\/2010\/06\/Shire-pharma-strategy.jpg","datePublished":"2010-06-15T10:43:36+00:00","dateModified":"2021-01-07T16:50:23+00:00","description":"Investors want to know the future direction of the company and how they intend to get there","breadcrumb":{"@id":"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/#primaryimage","url":"https:\/\/www.corporate-eye.com\/main\/wp-content\/uploads\/2010\/06\/Shire-pharma-strategy.jpg","contentUrl":"https:\/\/www.corporate-eye.com\/main\/wp-content\/uploads\/2010\/06\/Shire-pharma-strategy.jpg","width":580,"height":494,"caption":"Shire Strategy"},{"@type":"BreadcrumbList","@id":"https:\/\/www.corporate-eye.com\/main\/effective-investor-relations-sites-pt-18\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.corporate-eye.com\/main\/"},{"@type":"ListItem","position":2,"name":"What Makes for Effective Investor Relations Sites? Part 18: What\u2019s Your Strategy?"}]},{"@type":"WebSite","@id":"https:\/\/www.corporate-eye.com\/main\/#website","url":"https:\/\/www.corporate-eye.com\/main\/","name":"Corporate Eye","description":"...compare, compete, excel","publisher":{"@id":"https:\/\/www.corporate-eye.com\/main\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.corporate-eye.com\/main\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.corporate-eye.com\/main\/#organization","name":"Corporate Eye","url":"https:\/\/www.corporate-eye.com\/main\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.corporate-eye.com\/main\/#\/schema\/logo\/image\/","url":"https:\/\/www.corporate-eye.com\/main\/wp-content\/uploads\/2019\/11\/corporate-eye-logo.png","contentUrl":"https:\/\/www.corporate-eye.com\/main\/wp-content\/uploads\/2019\/11\/corporate-eye-logo.png","width":283,"height":42,"caption":"Corporate Eye"},"image":{"@id":"https:\/\/www.corporate-eye.com\/main\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/lucynixon"]},{"@type":"Person","@id":"https:\/\/www.corporate-eye.com\/main\/#\/schema\/person\/d273bf7421dc8f5fec96785876b760e2","name":"Lucy Nixon","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.corporate-eye.com\/main\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/538dc739f95aa5a2fd75d054808b18b2afa37a9282a7a8f87001a77dc128d759?s=96&d=identicon&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/538dc739f95aa5a2fd75d054808b18b2afa37a9282a7a8f87001a77dc128d759?s=96&d=identicon&r=g","caption":"Lucy Nixon"},"description":"Lucy is Editor at Corporate Eye","sameAs":["http:\/\/www.corporate-eye.com","https:\/\/x.com\/lucynixon"],"url":"https:\/\/www.corporate-eye.com\/main\/author\/lucy\/"}]}},"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.corporate-eye.com\/main\/wp-json\/wp\/v2\/posts\/33445","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.corporate-eye.com\/main\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.corporate-eye.com\/main\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.corporate-eye.com\/main\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.corporate-eye.com\/main\/wp-json\/wp\/v2\/comments?post=33445"}],"version-history":[{"count":7,"href":"https:\/\/www.corporate-eye.com\/main\/wp-json\/wp\/v2\/posts\/33445\/revisions"}],"predecessor-version":[{"id":52562,"href":"https:\/\/www.corporate-eye.com\/main\/wp-json\/wp\/v2\/posts\/33445\/revisions\/52562"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.corporate-eye.com\/main\/wp-json\/wp\/v2\/media\/33530"}],"wp:attachment":[{"href":"https:\/\/www.corporate-eye.com\/main\/wp-json\/wp\/v2\/media?parent=33445"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.corporate-eye.com\/main\/wp-json\/wp\/v2\/categories?post=33445"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.corporate-eye.com\/main\/wp-json\/wp\/v2\/tags?post=33445"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}